171 related articles for article (PubMed ID: 32552158)
1. 'Secondary prevention' against female HPV infection: literature review of the role of carrageenan.
Calagna G; Maranto M; Paola C; Capra G; Perino A; Chiantera V; Cucinella G
Expert Rev Anti Infect Ther; 2020 Sep; 18(9):865-874. PubMed ID: 32552158
[No Abstract] [Full Text] [Related]
2. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.
Roberts JN; Buck CB; Thompson CD; Kines R; Bernardo M; Choyke PL; Lowy DR; Schiller JT
Nat Med; 2007 Jul; 13(7):857-61. PubMed ID: 17603495
[TBL] [Abstract][Full Text] [Related]
3. Carrageenan is a potent inhibitor of papillomavirus infection.
Buck CB; Thompson CD; Roberts JN; Müller M; Lowy DR; Schiller JT
PLoS Pathog; 2006 Jul; 2(7):e69. PubMed ID: 16839203
[TBL] [Abstract][Full Text] [Related]
4. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
[TBL] [Abstract][Full Text] [Related]
5. Design and methods for the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) study: A randomized controlled trial.
Laurie C; Tota JE; El-Zein M; Tellier PP; Coutlée F; Burchell AN; Franco EL
Contemp Clin Trials; 2021 Nov; 110():106560. PubMed ID: 34487919
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Human Papillomavirus Vaccination for Secondary Prevention: A Systematic Review.
Dion GR; Teng S; Boyd LR; Northam A; Mason-Apps C; Vieira D; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2017 Jun; 143(6):614-622. PubMed ID: 28334393
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer.
Zhai L; Yadav R; Kunda NK; Anderson D; Bruckner E; Miller EK; Basu R; Muttil P; Tumban E
Antiviral Res; 2019 Jun; 166():56-65. PubMed ID: 30926288
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
11. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
12. Indications and efficacy of the human papillomavirus vaccine.
Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
[TBL] [Abstract][Full Text] [Related]
13. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
15. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH; Kim MK; Jeon YT; Kim YB; Song YS
Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
[TBL] [Abstract][Full Text] [Related]
17. Development of a β-HPV vaccine: Updates on an emerging frontier of skin cancer prevention.
Gupta R; Rady PL; Doan HQ; Tyring SK
J Clin Virol; 2020 May; 126():104348. PubMed ID: 32334327
[TBL] [Abstract][Full Text] [Related]
18. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
Castellsagué X; Klaustermeier J; Carrilho C; Albero G; Sacarlal J; Quint W; Kleter B; Lloveras B; Ismail MR; de Sanjosé S; Bosch FX; Alonso P; Menéndez C
Int J Cancer; 2008 Apr; 122(8):1901-4. PubMed ID: 18076064
[TBL] [Abstract][Full Text] [Related]
20. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
Husein-ElAhmed H
Int J STD AIDS; 2020 Jun; 31(7):606-612. PubMed ID: 32438856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
